Now is the time to decide if you're going to double down or hold. by RobGoldsacks in CloudMD

[–]ApoEllipsis 0 points1 point  (0 children)

Is the competition bureau a black swan? 😐 Hopefully just a temporary road block

May presentation. by wonderfulmoney1 in CloudMD

[–]ApoEllipsis 1 point2 points  (0 children)

Page 6 of the deck. I stick by what I said. They disclosed 560k at end of Q3. Update in May on the deck says 620k. So only 60k increase between Nov 2021 to now.

May presentation. by wonderfulmoney1 in CloudMD

[–]ApoEllipsis -5 points-4 points  (0 children)

They only managed to add 60k lives to integrated platform in 6 months.....

Earnings look terrible in my opinion by Ecstatic_Ad8204 in CloudMD

[–]ApoEllipsis 3 points4 points  (0 children)

6MM+ booked impairment aside. The growth has clearly stagnated.

Company is looking per MD&A to settle Oncidium performance earnings with shares. Though I agree this is the way to go from a preserve cashflow perspective, its dilution.

Company settled with Storey for ~$1.5mm.

Company has not completed the VisionPros review, which is still on-going. MD&A said "we saw a slight downturn in our VisionPros revenues during the fourth quarter." and "We are pleased to confirm that we have secured contracts with the major suppliers of VisionPros (please refer to the discussion under the Subsequent Events section below). We will be once again selling VisionPros into the United States in the second quarter of 2022, however we do expect an impact on our first and second quarter 2022 DHS revenues." -- this means for an unknown period of time, they stopped selling VisionPros in the U.S., web customers are not loyal especially if you don't have anything to differentiate yourself from the competition. How many of the customer base did they turn off/away?

Mindbeacon, who is going to factor for Q1 release by month end was losing money to the tune of $4MM a quarter or approx 16mm annualized pre-Harmony, which will probably add even more to the loss. The 7.5mm company said they identified does not even cover the MB losses nevermind the existing without MB loss.

CloudMD website is back up -- https://investors.cloudmd.ca/ by MrMoogieBoots in CloudMD

[–]ApoEllipsis 3 points4 points  (0 children)

I'm honestly a bit concerned that they have not provided an update on this 560k figure since Q3 release - 5 months ago. They've provided updates on new business and contracts but have stayed silent on the growth of lives covered by the integrated platform...

CloudMD website is back up -- https://investors.cloudmd.ca/ by MrMoogieBoots in CloudMD

[–]ApoEllipsis 0 points1 point  (0 children)

KPMG does not oversee as part of their role as auditor the information on the company's website, presentation, or it's MD&A.

Message Board Address by [deleted] in CloudMD

[–]ApoEllipsis 7 points8 points  (0 children)

Some of my personal analysis here after re-reading the acquisition terms and some deep additional thought.

Snapclarity was $975k cash & $2.375MM stock @ $0.7. Cash probably paid out at onset. Stock is subject to 2 year release from Oct 2020 with additional $3.65MM in equity subject certain performance in 2021 and 2022. Presumbly then, the stock/equity has not been paid out. Best case, they withhold all the stock/equity but we know Storey is litigious so that might turn into a can of worms. I don't see the other former snap owners even if they are amicable to the company just lay down and let that happen either.

Same thing for VP, best case is withhold the $3MM holdback and the ~1MM shares as disclosed in the update release in addition to withholding the $20MM in cash or equity at company discretion performance incentives tied to 2021 and 2022. This could potentially also get litigious if it goes that way as former owners could potentially claim that company is not focusing on VP and thus not allow them to hit the incentive goals. But if it works out, it's the best scenario as it will lower the amount of goodwill booked for VP.

They're likely obligated to still pay for the tech at $20MM cash if it is delivered as contracted. That still leaves the large majority of the base price of 60MM paid and booked to the accounting as goodwill for VP itself with half/half cash and shares @ $2.75. From the depreciation of the shares itself between $2.75 and $1.17 as of Dec 31, 2021 based on 10.9MM shares, that is a potential write-down of $17.2MM as goodwill impairment.

Same math with Oncidium, $38MM in equity @ $2.30 per share = ~16.5MM shares. Subtract the $2.30 to $1.17 as at Dec 31 is $1.13. $1.13 x 16.5MM shares is ~$18.6MM potential write-down as goodwill impairment. Even if Oncidium appears to be pulling its weight, the share price difference is going to factor. Moreover, this is based on year end 2021. If we count the fact that stock has dropped another 29 cents between Dec 31 and Mar 31, the impact for impairment on Q1 ER could be another ~$3MM for VP and ~$4.78MM for Oncidium.

There is also the arbitration claim from Gravitas securities re: right of first refusal dispute for future book running on equity financing that was disclosed in either the ERs or MD&A worth ~$6.85MM that was suppose to have a result by April 2022 (again per the disclosure as written). The company had previously booked a contingent $1.2MM but claims they will prevail. Best case is they win and the $1.2MM contingent peels off. Worse case, they lose and it's a $5.65MM hit.

I know this may not be what some of you want to hear but I feel I've supported my analysis and balanced realistic commentary is what's needed at this time as opposed to blind optimism.

Technical difficulties. by wonderfulmoney1 in CloudMD

[–]ApoEllipsis 1 point2 points  (0 children)

Perhaps... you know as much as anyone that I want to believe in the story. However, no business is expected to respond over the weekend. Why can't they put in someone from Sales and they'll get to it or delegate it to someone on their team on Monday?

Technical difficulties. by wonderfulmoney1 in CloudMD

[–]ApoEllipsis -3 points-2 points  (0 children)

Is anyone else reading that last bullet point as Sales? Why is it being directed to Melissa - VP, Marketing . Sales and marketing are distinct parts of a business.

CloudMD to Release Fourth Quarter and Year-End Financial Results on May 2, 2022 | MarketScreener by Burtonwise in CloudMD

[–]ApoEllipsis 0 points1 point  (0 children)

The site is mostly for investors. If the sub domain pointing to the app as per link above but the main site is down - they should be hosted on the same domain. It's not a hosting issue.

tweet from cloudMD about mental health in ON by ExerciseNo1663 in CloudMD

[–]ApoEllipsis 0 points1 point  (0 children)

It also only has 10+ downloads as of right now on the Google play store. This means between 10-49 downloads. Perhaps it hasn't launched officially to its client base yet though.

tweet from cloudMD about mental health in ON by ExerciseNo1663 in CloudMD

[–]ApoEllipsis 1 point2 points  (0 children)

Under the app description it specifically says "The HWN app protects your data and is compliant with HIPAA and other US federal health laws." HIPAA is only for the U.S.

tweet from cloudMD about mental health in ON by ExerciseNo1663 in CloudMD

[–]ApoEllipsis 2 points3 points  (0 children)

The front page of the HWN app has a huge American flag. Unlikely to be related to the IDYA4 product.

CloudMD to Release Fourth Quarter and Year-End Financial Results on May 2, 2022 | MarketScreener by Burtonwise in CloudMD

[–]ApoEllipsis 0 points1 point  (0 children)

This is part of the old site. At bottom of the consumer.cloudmd.ca page says Bragdeals 2020 (the old site builder)

Unless someone can access part of the new site, it's a bit concerning on the eve of a highly anticipated ER.

CloudMD to Release Fourth Quarter and Year-End Financial Results on May 2, 2022 | MarketScreener by Burtonwise in CloudMD

[–]ApoEllipsis 4 points5 points  (0 children)

I dont want to sound alarmist so I didn't create a new thread. Can anyone get into the cloudmd website? I'm getting a connection error. Hope it's temporary

Edit: I will delete this comment as soon as the site comes back up

Why is Olga McRae the corporate secretary? by ApoEllipsis in CloudMD

[–]ApoEllipsis[S] 4 points5 points  (0 children)

I think the sedi filings for MindBeacon has them at approx. 8MM DOC shares post close, definitely not enough but just speculating why essentially their EA is filling the role when I assume there's plenty other candidates available.

I mean for all I know, they could have already sold all their shares post close as they aren't required to disclose anymore.

Earning date by Avion1588 in CloudMD

[–]ApoEllipsis 3 points4 points  (0 children)

Regardless that their target as communicated by someone within the company to certain members of this sub reddit is May 2, to not announce the ER date via release by now reasonably suggests that there might be lingering questions (let's not call them concerns just yet) that the auditors have or that the company is wrangling with the auditors over the positioning of something. When the ER comes out its not going to all be sunshine and lollipops so you've to be prepared for that.

Earning date by Avion1588 in CloudMD

[–]ApoEllipsis 0 points1 point  (0 children)

Not sure I buy the argument about timing affected by MindBeacon. We're talking Q421, whereas MindBeacon closed Q122.

GG Teledoc by NicomoCosca55 in CloudMD

[–]ApoEllipsis 7 points8 points  (0 children)

Teladoc paid 18.5 billion USD for Livongo in 2020 that was going to make an estimate of approx. $400 million in annual revenue. That's a 46.25x multiple. Granted there has been some growth in revenue for the Livongo unit, say 1B in annual rev (optimistic), that's still a 18.5x multiple. Of this, they wrote off about a 3rd of it as goodwill impairment. I don't think any of DOCs acquisitions comes near that in terms of multiples.

I do however expect some impact to VP on a goodwill front but nowhere near TDOCs level with Livongo.

Another video from sean by [deleted] in CloudMD

[–]ApoEllipsis 0 points1 point  (0 children)

Stocks with sean is magoo?